1 / 25

Substance Use Disorders

Substance Use Disorders. How common are substance use disorders?. Alcohol use ~30% Americans ≥18 years old exceed recommended limits Smaller percentage have alcohol use disorder Illicit drugs ~9% Americans ≥12 years use Marijuana (7.5%)

dspear
Download Presentation

Substance Use Disorders

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Substance Use Disorders

  2. How common are substance use disorders? • Alcohol use • ~30% Americans ≥18 years old exceed recommended limits • Smaller percentage have alcohol use disorder • Illicit drugs • ~9% Americans ≥12 years use • Marijuana (7.5%) • Prescription drugs (2.5%, mostly opioids), Heroin (0.1%) • Cocaine (0.6%), Hallucinogens (0.5%), Inhalants (0.2%) • Methamphetamine a major problem in some regions • Designer drug use increasing (synthetic cannabinoids)

  3. What are the risk factors? • Genetic polymorphisms • May contribute 40% to 60% of an individual’s risk • Environmental factors in childhood or adolescence • Age of first exposure to alcohol or drugs • Adverse childhood experiences • Psychiatric comorbidities • Depression, anxiety, bipolar disorder • May contribute to vulnerability to addiction • Anxiety and depressive symptoms may be a consequence of long-term substance use

  4. Unhealthy substance use • Alcohol: consumption at a level that has negative health consequences • Men ≤65 years: risky use >4 drinks per occasion or >14 drinks per week • Men >65 years and women, risky use >3 drinks per occasion or >7 drinks per week • Unhealthy alcohol becomes a disorder when person experiences negative consequences and/or loss of control around their drinking • Drugs: ANY use

  5. What personal, community, and health system measures are effective in preventing substance use disorders? • Modeling abstinence or modest alcohol consumption • Awareness of risks of early drug or alcohol use • Policy measures that reduce underage drinking and other adverse drinking-related outcomes at all ages • Disposal of leftover controlled substance prescriptions • Education for physicians on safe opioid prescribing • Restrictions on dispensing opioid analgesics • Limits on quantity given in first opioid prescription

  6. What health system measures are effective in reducing or preventing unhealthy substance use? • Risky alcohol use: brief interventions can be effective • SBIRT: screening, brief intervention, referral to treatment • If screening positive: assess further and refer for treatment • Clinical cues should trigger investigation about alcohol use (pancreatitis, elevated liver function test results) • For drug use, brief interventions not shown effective • Use safe practices when prescribing opioids for pain • Ask about use: when social functioning deteriorates, family history is present, or associated comorbidities diagnosed (hep C, upper extremity abscess)

  7. How can opioids for chronic pain be prescribed safely and effectively? • Monitor for behaviors that indicate opioid use disorder • Predictors of opioid use disorder include • History or family history of substance use disorders • Mental health diagnosis • Current cigarette smoking • History of legal problems • Concurrent benzodiazepines, and higher opioid doses • Only consider long-term opioid treatment when • Moderate to severe pain affects function and/or QOL • Potential therapeutic benefits outweigh risks

  8. Use risk management strategies • Optimize alternatives to opioid treatment for chronic pain • Assess for risk for aberrant drug-related behaviors • Structure appropriate treatment and monitoring plan • Consider a medication agreement • Regularly assess opioid benefit and decision to use • Regularly assess drug-related behaviors, using urine drug testing, pill counts, state prescription monitoring data • Discontinue (tapering) if benefits are not commensurate with risks or if drug taking behaviors are aberrant • Seek appropriate specialist assistance

  9. CLINICAL BOTTOM LINE: Prevention... • Unhealthy alcohol use • Screening and brief interventions can reduce alcohol use • When managing chronic pain • Optimize alternatives to opioids • When opioid treatment considered, evaluate patients for risk factors for misuse • Regularly assesss opioid treatment • Monitor long-term use closely

  10. Diagnosis • Screening for alcohol use • Single-item: How many times have you consumed alcohol over the recommended limits? • AUDIT-C: 3-item survey more specific for unhealthy use • AUDIT: 10-item survey often used as follow-up to single-item question or as initial screening tool • CAGE: assesses lifetime rather than current use pattern • Screening for drug use • Single-item: How many times in the last year have you used an illegal drug, or a prescription medication for a nonmedical reason (bc of experience or feeling it caused)? • DAST-10: initial screening or follow up on single-item • Pay attention to key aspects of history

  11. Diagnosis • Assess withdrawal in patients with alcohol or opioid disorder who report recently stopping use • History and physical examination • CIWA (Clinical Institute Withdrawal Assessment) for alcohol withdrawal • COWS (Clinical Opiate Withdrawal Scale) score for opioid withdrawal • To further assess for complications of substance use • Laboratory evaluation often important

  12. Complications • Unhealthy alcohol use • Liver disease • Cardiovascular disease (hypertension, cardiomyopathy) • Gastritis, esophagitis • Bone marrow suppression, chronic infectious diseases • Peripheral neuropathy • Pneumonia • Several types of cancer • Increased morbidity in individuals with HIV, hep C • Psychiatric and behavioral conditions • Major risk factor for trauma and violence • Withdrawal can be fatal

  13. Complications • Injection drugs • Local infections (abscesses, cellulitis) • Blood-borne infections (bacterial and viral) • Opioids (in addition to complications of opioid injection) • Nausea and constipation • Effects of HPA axis suppression (amenorrhea, low bone density, loss of libido • Hyperalgesia • Overdose

  14. Complications • Cocaine • Cardiac ischemia, myocardial infarctions • Cerebrovascular and renal disease • Chronic rhinitis and perforation of the nasal septum • Smoking crack: acute, chronic pulmonary complications • Methamphetamine • Cardiotoxicity • Irritability; anger; panic; psychosis that may recur during periods of abstinence • Possible neurotoxicity and cognitive decline

  15. Complications • Marijuana • Pulmonary complications (cough, bronchitis, asthma) • Possible lung cancer or other cancers • Hyperemesis • In adolescents: abnormal development neural pathways • Possble depression and anxiety, psychotic disorders • Designer drugs • Synthetic cannabinoids: seizures, acute renal failure, myocardial infarction (long-term effects not well-known) • “Bath salts”: muscle spasm, bruxism, palpitations, tachycardia, hypertension; psychiatric effects • Oral health problems common with substance disorders

  16. CLINICAL BOTTOM LINE: Complications... • Substance use disorders have myriad medical complications • Unhealthy alcohol use: liver disease as well as causing or contributing to a host of other medical conditions • Injection drug use: local and systemic bacterial infections and blood-borne viruses, including HIV and hepatitis C • Cocaine: cardiovascular effects • Marijuana: pulmonary complications, neurocognitive impairment that may be particularly serious in adolescents

  17. How should withdrawal be approached in the outpatient setting? • Goals of withdrawal management • Manage symptoms • Prevent serious complications • Bridge to treatment to achieve long-term recovery • Outpatient management may be appropriate for select, highly motivated and supported patients • Plan is needed for ongoing care • Withdrawal management is not substance use treatment

  18. Alcohol: criteria for outpatient detoxification • CIWA score 8 - 15 without seizures or delirium tremens • Ability to take oral medications • Presence of reliable support person who can stay throughout the detox period and monitor symptoms • Ability to commit to daily medical visits • No unstable medical condition and not pregnant • Not psychotic, suicidal, or cognitively impaired • No concurrent substance use that may lead to withdrawal • No history delirium tremens or alcohol withdrawal seizures • Contraindications: >60 y, evidence alcohol-related end-organ damage • Benzodiazepines may help manage symptoms and prevent complications

  19. Opioids • Treating as outpatients depends on treatment goals and treatment availability • Refer patients experiencing withdrawal and interested in methadone / buprenorphine treatment for such care • For oral naltrexone use, patient must be opioid abstinent 3–7 d before initiation; for intramuscular formulation ≥7 d • Patients often require structure and supervision of inpatient setting during this transition • In outpatient setting, manage symptoms with nonopioid medications for anxiety, cramps, diarrhea • Benzodiazepines • Manage severe withdrawal as inpatients so that IV benzodiazepines can be given and titrated to effect • Afterward, motivated patients can receive gradually tapering dose in outpatient setting over several months

  20. What medications are available for treatment? • Alcohol • Naltrexone • Acamprosate • Disulfiram • Opioids • Methadone • Buprenorphine • Sustained-release naltrexone • Cocaine • No FDA-approved medication

  21. What other treatments are available for substance use disorders? • Psychosocial treatment • Helps achieve sobriety, rebuild other aspects of life • Counseling • Peer-support groups (Alcoholics Anonymous) • Residential treatment • Contingency management • Motivational interviewing

  22. For patients who continue to use substances, how can physicians help reduce harms? • Needle exchange services: injection drug users • Intranasal naloxone: opioid use disorder • Tetanus, hepatitis A & B vaccination: injection drug users • Pneumonia vaccination: alcohol use disorders • Preexposureprophylaxis against HIV: high-risk patients • Counsel to avoid driving after unhealthy alcohol, drug use • Offer birth control, condom counseling, frequent STI testing to women with heroin use disorders • Engage patients in discussions about readiness for change • Address tobacco use just as with any other patient

  23. What are the medical-legal issues of substance use disorders? • State legislation • May affect how physicians prescribe opioids and other controlled substances • Federal regulations • Title 42, part 2: requires higher degree of confidentiality than standard medical information • Practices should incorporate 42 CFR part 2-compliant language into standard clinic release of information forms

  24. What is the role of primary care physicians vs. addiction physicians and other specialists? • Primary care physicians • Central roles in prevention, diagnosis, and management • May treat patients with substance use disorders • Referral to addiction specialist and/or treatment program • Addiction specialists • Complex patients with substance use disorders • Addiction psychiatry subspecialists • Patients with mental health condition • Pain specialists • Optimize nonopioid treatments of chronic pain

  25. CLINICAL BOTTOM LINE: Management... • Withdrawal management • Necessary bridge to further treatment for many patients • Outpatient management appropriate only for highly motivated patients with ample support at home • Treatment options • Medications available for alcohol and opioid use disorders • Psychosocial treatments effective for many patients • Peer-support groups (Alcoholics Anonymous) may benefit • Educate patients who are in early recovery or who are not ready to stop substance use about harm reduction

More Related